User profiles for Yuriko Katsumata

Yuriko Katsumata

University of Kentucky
Verified email at g.uky.edu
Cited by 2859

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

…, SRK Hokkanen, S Hunter, GA Jicha, Y Katsumata… - Brain, 2019 - academic.oup.com
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43
encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a …

Brain arteriolosclerosis

…, JA Schneider, RN Kalaria, Y Katsumata… - Acta …, 2021 - Springer
Brain arteriolosclerosis (B-ASC), characterized by pathologic arteriolar wall thickening, is a
common finding at autopsy in aged persons and is associated with cognitive impairment. …

Prevalence and clinical phenotype of quadruple misfolded proteins in older adults

S Karanth, PT Nelson, Y Katsumata, RJ Kryscio… - JAMA …, 2020 - jamanetwork.com
Importance Quadruple misfolded proteins (tau neurofibrillary tangles, amyloid-β [Aβ], α-synuclein,
and transactive response DNA-binding protein 43 [TDP-43]) in the same brain are …

Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals

…, DW Fardo, AL Lin, Y Katsumata… - Journal of Cerebral …, 2017 - journals.sagepub.com
Risk factors and cognitive sequelae of brain arteriolosclerosis pathology are not fully understood.
To address this, we used multimodal data from the National Alzheimer's Coordinating …

Evaluation of CD33 as a genetic risk factor for Alzheimer's disease

S Estus, BC Shaw, N Devanney, Y Katsumata… - Acta …, 2019 - Springer
In 2011, genome-wide association studies implicated a polymorphism near CD33 as a
genetic risk factor for Alzheimer’s disease. This finding sparked interest in this member of the …

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease

…, A Iyappan, Q Jiang, Y Katsumata… - Alzheimer's & …, 2016 - Wiley Online Library
Identifying accurate biomarkers of cognitive decline is essential for advancing early
diagnosis and prevention therapies in Alzheimer's disease. The Alzheimer's disease DREAM …

Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction

FM Marottoli, Y Katsumata, KP Koster, R Thomas… - ASN …, 2017 - journals.sagepub.com
Cerebrovascular dysfunction is rapidly reemerging as a major process of Alzheimer’s disease
(AD). It is, therefore, crucial to delineate the roles of AD risk factors in cerebrovascular …

[HTML][HTML] Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort

…, JM Barber, LJ Van Eldik, Y Katsumata… - Acta Neuropathologica …, 2023 - Springer
In addition to the memory disorders and global cognitive impairment that accompany
neurodegenerative diseases, behavioral and psychological symptoms of dementia (BPSD) …

[HTML][HTML] Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and …

Y Katsumata, DW Fardo, WA Kukull… - Acta neuropathologica …, 2018 - Springer
TAR-DNA binding protein 43 (TDP-43) proteinopathy is a common brain pathology in elderly
persons, but much remains to be learned about this high-morbidity condition. Published …

[HTML][HTML] Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities

Y Katsumata, LM Shade, TJ Hohman… - Neurobiology of …, 2022 - Elsevier
The classic pathologic hallmarks of Alzheimer's disease (AD) are amyloid plaques and
neurofibrillary tangles (AD neuropathologic changes, or ADNC). However, brains from …